Literature DB >> 1377276

Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

I Lerer1, M Sagi, G R Cutting, D Abeliovich.   

Abstract

We have screened our CF patients for mutations in exons 10 and 11 of the CFTR gene. Two mutations, delta F508 and G542X, have been found in 66 Jewish CF patients. The average frequency of the delta F508 mutation in the Jewish population is 33.8%. The G542X mutation accounts for 13% of the Ashkenazi CF mutations and has been found in three out of seven chromosomes of Jewish patients from Turkey (probably descended from Ashkenazi immigrants). The G542X mutation was not found in any of the other non-Ashkenazi patients. All the G542X bearing chromosomes have the same haplotype. Based on these observations it is concluded that the G542X mutation was introduced into the Jewish people after the split into Ashkenazi and non-Ashkenazi.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377276      PMCID: PMC1015854          DOI: 10.1136/jmg.29.2.131

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Cystic fibrosis in Greece: typing with DNA probes and identification of the common molecular defect.

Authors:  A Balassopoulou; D Loukopoulos; P Kollia; M Devoto; G Adam; S Arvanitakis; H Hadjisevastou
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  The haplotype distribution of the delta F508 mutation in cystic fibrosis families in Scotland.

Authors:  I McIntosh; A Curtis; M L Lorenzo; M Keston; A J Gilfillan; G Morris; D J Brock
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

3.  Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients.

Authors:  L Cremonesi; L Ruocco; M Seia; S Russo; A Giunta; P Ronchetto; L Fenu; L Romano; M Devoto; G Romeo
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

4.  Population analysis of the major mutation in cystic fibrosis.

Authors:  L C Tsui
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

5.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.

Authors:  I Lerer; S Cohen; M Chemke; A Sanilevich; J Rivlin; A Golan; J Yahav; A Friedman; D Abeliovich
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

7.  DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis.

Authors:  C L Rosenbloom; B S Kerem; J M Rommens; L C Tsui; B Wainwright; R Williamson; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

8.  Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism.

Authors:  G L Feldman; R Williamson; A L Beaudet; W E O'Brien
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

9.  Cystic fibrosis haplotype association and the delta F508 mutation in adult British CF patients.

Authors:  G Santis; L Osborne; R Knight; M Ramsay; R Williamson; M Hodson
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

10.  Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

Authors:  M Vidaud; P Fanen; J Martin; N Ghanem; S Nicolas; M Goossens
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

View more
  5 in total

1.  Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

Authors:  D Abeliovich; I P Lavon; I Lerer; T Cohen; C Springer; A Avital; G R Cutting
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.

Authors:  G R Cutting; S M Curristin; E Nash; B J Rosenstein; I Lerer; D Abeliovich; A Hill; C Graham
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

3.  Implications for health and disease in the genetic signature of the Ashkenazi Jewish population.

Authors:  Saurav Guha; Jeffrey A Rosenfeld; Anil K Malhotra; Annette T Lee; Peter K Gregersen; John M Kane; Itsik Pe'er; Ariel Darvasi; Todd Lencz
Journal:  Genome Biol       Date:  2012-01-25       Impact factor: 13.583

4.  Characterization of Ancestral Origin of Cystic Fibrosis of Patients with New Reported Mutations in CFTR.

Authors:  César Paz-Y-Miño; Ana Karina Zambrano; Juan Carlos Ruiz-Cabezas; Isaac Armendáriz-Castillo; Jennyfer M García-Cárdenas; Santiago Guerrero; Andrés López-Cortés; Andy Pérez-Villa; Patricia Guevara-Ramírez; Verónica Yumiceba; Paola E Leone
Journal:  Biomed Res Int       Date:  2020-05-29       Impact factor: 3.411

5.  Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.

Authors:  Emery Smith; Danijela Dukovski; Justin Shumate; Louis Scampavia; John P Miller; Timothy P Spicer
Journal:  SLAS Discov       Date:  2020-10-05       Impact factor: 3.341

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.